Phoenix Medicaments Private Limited - Company Profile

It is a healthcare private limited company based in Ahmedabad, Gujarat, India, established in 2013.
2013 Ahmedabad, Gujarat, India Active
Last Updated:
About Phoenix Medicaments Private Limited

Phoenix Medicaments Private Limited, a active private limited company, was established on 04 September 2013 in Ahmedabad, Gujarat, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U24100GJ2013PTC076688. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Arva Mustuffa Baldiwala (Director), Rashida Shakirhusen Baldiwala (Director), Mustuffa Shakirhusen Baldiwala (Director). Past directors included Arva Mustuffa Baldiwala. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No 2, Shreeji Complex, Opp. Ellisbridge Post Office, Ellisbridg, E, Ahmedabad, Gujarat, 380006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100GJ2013PTC076688

  • Registration Number

    076688

  • Incorporation Date

    04 September 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -14.86%
  • Profit Growth **** -46.52%
  • Ebitda **** -32.70%
  • Net Worth 41.11%
  • Total Assets **** 16.66%
Company report

Phoenix Medicaments Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Phoenix Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Phoenix Medicaments Private Limited?
Current Directors
Name Designation Appointment Date Status
Arva Mustuffa Baldiwala Director 20 Jan 2017 Current
Rashida Shakirhusen Baldiwala Director 04 Sep 2013 Current
Mustuffa Shakirhusen Baldiwala Director 04 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Phoenix Medicaments.

Phoenix Medicaments Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.86% decrease. The company also saw a substantial fall in profitability, with a 46.52% decrease in profit. The company's net worth Soared by an impressive increase of 41.11%.

Phoenix Medicaments revenue growth over time
Phoenix Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-14.86%
*******
*******
*******
*******
Revenue from Operations
*******
-15.10%
*******
*******
*******
*******
Total Assets
*******
16.66%
*******
*******
*******
*******
Profit or Loss
*******
-46.52%
*******
*******
*******
*******
Net Worth
*******
41.11%
*******
*******
*******
*******
EBITDA
*******
-32.70%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Phoenix Medicaments?

Unlock access to Phoenix Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Phoenix Medicaments?

Unlock and access historical data on people associated with Phoenix Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Phoenix Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Phoenix Medicaments
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Phoenix Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Phoenix Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Arva Mustuffa Baldiwala was appointed as a Director was appointed as a Director on 20 Jan 2017 & has been associated with this company since 9 years 25 days . was recorded as a recent event.

  • Director Appointment

    The activity Rashida Shakirhusen Baldiwala was appointed as a Director was appointed as a Director on 04 Sep 2013 & has been associated with this company since 12 years 5 months . was completed.

  • Director Appointment

    Progress on Mustuffa Shakirhusen Baldiwala was appointed as a Director was appointed as a Director on 04 Sep 2013 & has been associated with this company since 12 years 5 months . was documented.

  • Company Incorporation

    The activity Phoenix Medicaments Private Limited was registered on 04 Sep 2013 with Roc Ahmedabad & aged 12 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Phoenix Medicaments Private Limited?

The CIN of Phoenix Medicaments Private Limited is U24100GJ2013PTC076688.

Where is Phoenix Medicaments Private Limited headquartered?

Phoenix Medicaments Private Limited is headquartered at Shop No 2, Shreeji Complex, Opp. Ellisbridge Post Office, Ellisbridg, E, Ahmedabad, Gujarat, 380006.

When was Phoenix Medicaments Private Limited incorporated?

Phoenix Medicaments Private Limited was incorporated on 04 September 2013.

Who are the current directors of Phoenix Medicaments Private Limited?

The current directors of Phoenix Medicaments Private Limited are

What is the primary industry of Phoenix Medicaments Private Limited?

The primary industry of Phoenix Medicaments Private Limited is Trade.

Is Phoenix Medicaments Private Limited a listed company?

Phoenix Medicaments Private Limited is unlisted.

What is the capital structure of Phoenix Medicaments Private Limited?

The authorized capital of Phoenix Medicaments Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Phoenix Medicaments Private Limited?

The compliance status of Phoenix Medicaments Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available